Peripheral Nerve Stimulator Market
Peripheral Nerve Stimulator Market Study by Transcutaneous and Implantable for Hospitals and Outpatient Centres from 2024 to 2034
Analysis of Peripheral Nerve Stimulator Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Peripheral Nerve Stimulator Market Outlook (2024 to 2034)
Worldwide revenue from peripheral nerve stimulator market size is set to reach US$ 540.9 million in 2024. As per this detailed research study by Fact.MR, the market is projected to climb to a value of US$ 1.09 billion by the end of 2034, expanding at a CAGR of 7.2%.
When neuromuscular blocking agents (NMBAs) are used to stop musculoskeletal activity, a peripheral nerve stimulator, commonly referred to as a train-of-four monitor, is utilized to evaluate neuromuscular transmission.
Peripheral nerve stimulation ensures an appropriate pharmaceutical dose and reduces adverse effects by measuring the degree of neuromuscular inhibition. In the intensive care unit (ICU), peripheral nerve stimulation is widely utilized for continuous monitoring. For the sickest patients, NMBAs are utilized to lessen respiratory effort and make mechanical ventilation easier.
When peripheral nerve stimulation monitoring is used during NMBA administration, less medicine is needed, which speeds up the recovery of spontaneous breathing and neuromuscular transmission when the NMBA is stopped.
Advancements in neuromodulation technology and a growing focus on individualized pain treatment strategies are contributing to the peripheral nerve stimulator market size. The effectiveness and accuracy of nerve stimulation treatments are being improved by developments in electrode design, stimulation algorithms, and device downsizing.
Key Market Growth Drivers
- Peripheral nerve stimulation is widely used to treat patients with conditions such as neuropathic pain, complex regional pain syndrome, and some types of arthritis instead of more traditional pain treatment methods.
- Growing demand for effective pain management treatments such as neuromodulation therapies, particularly from the aging population is boosting the adoption of peripheral nerve stimulators.
- Advancements in peripheral nerve stimulation technologies such as improvements in electrode designs, stimulation algorithms, and device downsizing are boosting demand.
- Peripheral nerve stimulator devices are now becoming more convenient and easier to use due to the addition of wireless connectivity and programming platforms based on smartphones.
- With implanted pulse generators and rechargeable batteries, ambulatory peripheral nerve stimulator systems allow patients to get therapy without having to stay overnight, facilitating a quicker recovery and improved quality of life.
- Other than pain treatment, peripheral nerve stimulation is widely used in neurology, rehabilitation medication, orthopedics, and several other therapeutic domains.
- Peripheral nerve stimulation devices are useful in treating various medical disorders due to their adaptability in focusing on certain nerves or neural pathways, which helps patients restore function and feel better.
- Ongoing market trends are the increasing focus and the need for minimally invasive and outpatient pain management techniques.
- Peripheral nerve stimulator market growth is primarily driven by the rising prevalence of chronic pain such as neuropathic pain, back pain, and arthritis.
| Report Attribute | Detail |
|---|---|
| Peripheral Nerve Stimulator Market Size (2024E) | US$ 540.9 Million |
| Forecasted Market Value (2034F) | US$ 1.09 Billion |
| Global Market Growth Rate (2024 to 2034) | 7.2% CAGR |
| North America Market Share (2024E) | 36.4% |
| Latin America Market Value (2024E) | US$ 37.63 Million |
| Sales of Transcutaneous Peripheral Nerve Stimulators (2034F) | US$ 757.4 Million |
| Revenue from Product Use in Outpatient Centers (2034F) | US$ 716.2 Million |
| Key Companies Profiled | Abbott; Boston Scientific Corporation; Advanced Bionics; Braun SE; Novum Therapeutics; Medtronic; Respicardia; BioControl Medical; SPR Therapeutics; Teleflex Incorporated. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What is a Key Peripheral Nerve Stimulator Market Trend?
“Technological Advancements Enhancing Patient Comfort and Efficacy of Nerve Stimulation Treatments”
The market for peripheral nerve stimulators is expanding at a significant pace due to technological advancements that are improving the comfort of patients and the efficacy of nerve stimulation treatments. These developments include enhancements in electrode design to enable more accurate targeting of nerves, maximizing therapeutic results while reducing adverse effects. Advanced simulation algorithms are improving patient comfort and satisfaction and enabling customized therapy techniques.
Peripheral nerve stimulation devices are becoming smaller, more portable, and unobtrusive, which helps end users manage them more effectively. The combination of smartphone-based programming platforms and wireless connectivity is improving usability by allowing patients and professionals to remotely monitor and modify their therapy settings, which enhances treatment compliance.
What is the Main Hurdle Hindering Market Expansion?
“High Treatment Cost Reducing Treatment Accessibility for Patients with Budget Constraints”
High costs of treatments using peripheral nerve stimulation are becoming a barrier to market expansion as it reduces the accessibility for many patients who have budget-constrained or limited healthcare coverage. The high cost of peripheral nerve stimulators also impacts healthcare facilities due to high initial investment requirements and continuous maintenance expenditures. Continuous maintenance expenses and replacement costs are limiting the adoption and utilization of these devices.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
North America is estimated to hold 36.4% of the worldwide peripheral nerve stimulator market share in 2024 due to the availability of well-developed healthcare centers. Eastern & Western Europe are expected to account for a significant market share throughout the projection period due to increasing spending on healthcare sector enhancements and the rising number of nerve injury patients.
What’s Attracting Patients Seeking Relief from Chronic Pain to the United States?
“Availability of Advanced Nerve Stimulator Devices and Skilled Healthcare Professionals”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 169 Million |
| Growth Rate (2024 to 2034) | 5.7% CAGR |
| Projected Value (2034F) | US$ 295 Million |
Advanced healthcare sector in the United States is the primary factor that is contributing to market expansion in the country. Demand for peripheral nerve stimulator devices is increasing due to technological innovations. Investments in technological advancements are facilitating the launch of new products, benefiting both patients and end users by enhancing outcomes and simplifying treatment procedures. Advanced devices and skilled healthcare professionals in the United States are attracting patients from various countries seeking treatment.
Why are Manufacturers and Suppliers of Peripheral Nerve Stimulators Drawn to Brazil?
“Increasing R&D Investments and Government Support for Enhancing Treatment Efficacy”
| Attribute | Brazil |
|---|---|
| Market Value (2024E) | US$ 20.83 Million |
| Growth Rate (2024 to 2034) | 8.2% CAGR |
| Projected Value (2034F) | US$ 45.93 Million |
Key reason behind the increasing demand for peripheral nerve stimulators in Brazil is the rising prevalence of chronic pain conditions, boosting the need for advanced pain management devices. Other than these factors, excellent reimbursement policies and increasing investments in the healthcare sector are also contributing to market expansion in the country. Also, government initiatives for enhancing treatment efficacy and increasing investment in research and development activities are attracting suppliers and buyers.
Category-wise Insights
By product type, the market is segmented into transcutaneous and implantable peripheral nerve stimulators. Even though the transcutaneous segment is estimated to hold a significant market share, the demand for implantable peripheral nerve stimulators is projected to rise at 7.9% CAGR through 2034.
Which Type of Peripheral Nerve Stimulator Accounts for Higher Sales?
“Portability and Compact Size of Transcutaneous Peripheral Nerve Stimulators Driving Sales”
| Attribute | Transcutaneous Peripheral Nerve Stimulators |
|---|---|
| Segment Value (2024E) | US$ 387.2 Million |
| Growth Rate (2024 to 2034) | 6.9% CAGR |
| Projected Value (2034F) | US$ 757.4 Million |
Demand for transcutaneous peripheral nerve stimulators is rising because they provide a non-invasive method of pain management which makes them the preferred choice for people who want an alternative to medication or invasive methods. Portability and small size are benefits of these devices due to which they are usable at home. Other than this, increasing attention toward complementary and alternative medication is also contributing to the increasing demand for transcutaneous peripheral nerve stimulators.
Transcutaneous electrical nerve stimulation, which works by suppressing glial activation, increasing gamma-aminobutyric acid and glycine levels, and decreasing the sensitivity of dorsal horn neurons, is a popular therapeutic strategy for both acute and chronic pain relief.
Why is There Rising Need for Peripheral Nerve Stimulators in Outpatient Centers?
“Rising Adoption of Minimally Invasive Alternatives for Treating Chronic Pain in Outpatient Care”
| Attribute | Outpatient Centers |
|---|---|
| Segment Value (2024E) | US$ 352.8 Million |
| Growth Rate (2024 to 2034) | 7.3% CAGR |
| Projected Value (2034F) | US$ 716.2 Million |
Rising need for peripheral nerve stimulators in outpatient centers is driven by their critical role as a minimally invasive alternative for treating chronic pain. Peripheral nerve stimulators offer focused pain management, enabling patients to go home soon after the treatment, which is in line with the expediency and quick recovery objectives of the outpatient environment.
Peripheral nerve stimulators are now safer and more effective because of technological developments, which have led to a rise in their use in outpatient settings. Peripheral nerve stimulators are included in outpatient care in response to the increased emphasis on multimodal methods of pain management, which has satisfied patient demand for extensive and customized treatment alternatives.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
Key players in the peripheral nerve stimulator market such as Boston Scientific Corporation, Medtronic, Abbott Laboratories, and many others are expanding their product portfolio and global reach to maintain their market position and increase profit. An increasing number of start-ups are making the market competitive, which makes companies innovate new products. Also, the growing focus on making peripheral nerve stimulator devices digitally controlled, manufacturing in small and portable sizes, and reducing cost without compromising on quality is boosting the adoption of these devices, which is benefitting market players.
- In May 2024, SPR Therapeutics released encouraging findings from a trial involving their peripheral nerve stimulation (PNS) device to assist patients after knee replacement surgery who are suffering from persistent knee discomfort.
- In February 2024, to increase sales of its Sprint PNS painkilling device, SPR Therapeutics raised US$ 85 million.
- In January 2024, in a Series E funding round, United States-based Nalu Medical secured US$ 65 million to further the development and commercialization of its neurostimulation device for treating chronic pain.
- In January 2024, the United States FDA approved Neuralace Medical’s ground-breaking medication, Axon Therapy (mPNS), for the treatment of persistent painful diabetic neuropathy (PDN).
- In August 2023, GlobalSpace, India's first telehealth provider, and local neurotech wellness start-up Roga struck a multimillion-dollar deal. The US$ 35 million contract is Roga's first significant healthcare agreement and a first step toward providing white-label services globally.
Fact.MR provides detailed information about the price points of leading manufacturers of peripheral nerve stimulators positioned across the world, sales growth, production capacity, and speculative technological expansion in this new market report.
Segmentation of Peripheral Nerve Stimulator Market Research
-
By Product Type :
- Transcutaneous
- Implantable
-
By End User :
- Hospitals
- Outpatient Centers
-
By Region :
- North America
- Western Europe
- Eastern Europe
- Latin America
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 6.1. Product Type
- 6.2. End User
- 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Product Type
- 7.1. Transcutaneous
- 7.2. Implantable
- 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by End User
- 8.1. Hospitals
- 8.2. Outpatient Centers
- 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Western Europe
- 9.4. Eastern Europe
- 9.5. East Asia
- 9.6. South Asia & Pacific
- 9.7. Middle East & Africa
- 10. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 11. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 12. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 13. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 14. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 15. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 16. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 17. Sales Forecast 2024 to 2034 by Product Type, End User, and Region for 30 Countries
- 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 19. Company Profile
- 19.1. Abbott
- 19.2. Boston Scientific Corporation
- 19.3. Advanced Bionics
- 19.4. Braun SE
- 19.5. Novum Therapeutics
- 19.6. Medtronic
- 19.7. Respicardia
- 19.8. BioControl Medical
- 19.9. SPR Therapeutics
- 19.10. Teleflex Incorporated
- 20. Assumptions and Acronyms Used
- 21. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 02: Global Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 04: Global Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 05: Global Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 07: Global Market Value (US$ Mn) Analysis, by Region, 2019 to 2023
Table 08: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 10: North America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 11: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 12: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 13: North America Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 14: North America Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 16: North America Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 17: North America Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 19: Latin America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 20: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 21: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 22: Latin America Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 23: Latin America Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 24: Latin America Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 25: Latin America Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 26: Latin America Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 28: Western Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 29: Western Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 30: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 31: Western Europe Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 32: Western Europe Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 33: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 34: Western Europe Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 35: Western Europe Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 36: Western Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 37: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 38: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 39: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 40: Eastern Europe Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 41: Eastern Europe Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 42: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 43: Eastern Europe Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 44: Eastern Europe Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 45: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 46: East Asia Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 47: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 48: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 49: East Asia Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 50: East Asia Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 52: East Asia Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 53: East Asia Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 55: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 56: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 57: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 58: South Asia & Pacific Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 59: South Asia & Pacific Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 60: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 61: South Asia & Pacific Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 62: South Asia & Pacific Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 63: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 64: MEA Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 65: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 66: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 67: MEA Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 68: MEA Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 69: MEA Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 70: MEA Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 71: MEA Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 72: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 05: Global Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 07: Global Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 08: Global Market Share and BPS Analysis by End User, 2024 & 2034
Figure 09: Global Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by End User, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 14: North America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 15: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 16: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 17: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 18: North America Market Share Analysis by Country, 2024 & 2034
Figure 19: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 20: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 21: North America Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 22: North America Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 24: North America Market Share and BPS Analysis by End User, 2024 & 2034
Figure 25: North America Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 26: North America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 27: Latin America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 28: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 29: Latin America Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 30: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 31: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 32: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 33: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 34: Latin America Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 35: Latin America Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 36: Latin America Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 37: Latin America Market Share and BPS Analysis by End User, 2024 & 2034
Figure 38: Latin America Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 39: Latin America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 40: Western Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 41: Western Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 42: Western Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 43: Western Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 44: Western Europe Market Share Analysis by Country, 2024 & 2034
Figure 45: Western Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 46: Western Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 47: Western Europe Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 48: Western Europe Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 49: Western Europe Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 50: Western Europe Market Share and BPS Analysis by End User, 2024 & 2034
Figure 51: Western Europe Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 52: Western Europe Market Attractiveness Analysis by End User, 2024 to 2034
Figure 53: Eastern Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 54: Eastern Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 55: Eastern Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 56: Eastern Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 57: Eastern Europe Market Share Analysis by Country, 2024 & 2034
Figure 58: Eastern Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 59: Eastern Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 60: Eastern Europe Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 61: Eastern Europe Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 62: Eastern Europe Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 63: Eastern Europe Market Share and BPS Analysis by End User, 2024 & 2034
Figure 64: Eastern Europe Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 65: Eastern Europe Market Attractiveness Analysis by End User, 2024 to 2034
Figure 66: East Asia Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 67: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 68: East Asia Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 69: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 70: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 71: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 72: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 73: East Asia Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 74: East Asia Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 75: East Asia Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 76: East Asia Market Share and BPS Analysis by End User, 2024 & 2034
Figure 77: East Asia Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 78: East Asia Market Attractiveness Analysis by End User, 2024 to 2034
Figure 79: South Asia & Pacific Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 80: South Asia & Pacific Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 81: South Asia & Pacific Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 82: South Asia & Pacific Market Incremental $ Opportunity, 2024 to 2034
Figure 83: South Asia & Pacific Market Share Analysis by Country, 2024 & 2034
Figure 84: South Asia & Pacific Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 85: South Asia & Pacific Market Attractiveness Analysis by Country, 2024 to 2034
Figure 86: South Asia & Pacific Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 87: South Asia & Pacific Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 88: South Asia & Pacific Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 89: South Asia & Pacific Market Share and BPS Analysis by End User, 2024 & 2034
Figure 90: South Asia & Pacific Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 91: South Asia & Pacific Market Attractiveness Analysis by End User, 2024 to 2034
Figure 92: MEA Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 93: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 94: MEA Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 95: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 96: MEA Market Share Analysis by Country, 2024 & 2034
Figure 97: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 98: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 99: MEA Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 100: MEA Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 101: MEA Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 102: MEA Market Share and BPS Analysis by End User, 2024 & 2034
Figure 103: MEA Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 104: MEA Market Attractiveness Analysis by End User, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the peripheral nerve stimulator market in 2024?
The global market for peripheral nerve stimulators is forecasted to reach US$ 540.9 million in 2024.
What is the future projection for the peripheral nerve stimulator market?
Worldwide sales of peripheral nerve stimulators are projected to reach US$ 1.09 billion by 2034-end.
At what rate is the demand for peripheral nerve stimulators projected to increase?
Demand for peripheral nerve stimulators is forecasted to rise at 7.2% CAGR through 2034.
Who are the key suppliers of peripheral nerve stimulators?
Top companies in the market are Abbott, Boston Scientific Corporation, Advanced Bionics, Braun SE, and Novum Therapeutics.
Which end-use segment is anticipated to lead revenue generation?
Utilization of peripheral nerve stimulators in outpatient centers is projected to generate revenue worth US$ 716.2 million by 2034.
Which region holds a high global market share?
North America is estimated to account for 36.4% of the global market share in 2024.
At what rate is the market projected to expand in Chile?
The market in Chile is projected to expand at 8.5% CAGR through 2034.
Which peripheral nerve stimulator product accounts for high demand?
Sales of transcutaneous peripheral nerve stimulators are calculated to reach US$ 387.2 million in 2024.
Peripheral Nerve Stimulator Market